ASBCA 62633
Board: ASBCA
Agency: Defense Contract Management Agency
Appellant: Ology Bioservices, Inc.
Date: 2021-05-20
Outcome: sustained
ARMED SERVICES BOARD OF CONTRACT APPEALS
Appeal of - )
)
Ology Bioservices, Inc. ) ASBCA No. 62633
)
Under Contract No. W911QY-13-C-0010 )
et al. )
APPEARANCES FOR THE APPELLANT: Richard B. OâKeeffe Jr., Esq.
Gary S. Ward, Esq.
Nicole E. Giles, Esq.
Wiley Rein LLP
Washington, DC
APPEARANCES FOR THE GOVERNMENT: Arthur M. Taylor, Esq.
Chief Trial Attorney
Patrick B. Grant, Esq.
Trial Attorney
Defense Contract Management Agency
Chantilly, VA
OPINION BY ADMINISTRATIVE JUDGE OâCONNELL
ON CROSS-MOTIONS FOR SUMMARY JUDGMENT
This appeal involves a penalty for expressly unallowable costs, namely,
executive compensation costs above the threshold established by the Office of Federal
Procurement Policy (OFPP). The parties have cross-moved for summary judgment.
The Board grants appellantâs motion and denies the governmentâs cross-motion.
STATEMENT OF FACTS (SOF) FOR PURPOSES OF THE MOTION
The following facts are undisputed for purposes of the motions.
Between 2011 and 2013, appellant, Ology Bioservices, Inc. (Ology) entered
into four cost reimbursement contracts with the government, including the contract
referenced above. A Defense Contract Management Agency (DCMA)
contracting officer (CO) was responsible for negotiating and establishing Ologyâs final
indirect cost rates for the contracts. (Appellantâs statement of undisputed facts
(ASUMF) ¶¶ 3-4; Government statement of genuine issues of material fact (GSMF)
¶¶ 3-4; R4, tab 8).
The contracts included FAR 52.242-3, PENALTIES FOR UNALLOWABLE
COSTS (MAY 2001), which provides for the assessment of a penalty for costs
submitted by the contractor in its proposal that are âexpressly unallowable
under cost principle in the FAR . . . .â (FAR 52.242-3(d); ASUMF ¶¶ 5, 20; R4, tab 1
at G-000099). The contracts also included FAR 52.242-4, CERTIFICATION OF
FINAL INDIRECT COSTS (JAN 1997), which requires a senior official of the
contractor to certify, among other things, that the final indirect cost rates do not
include any costs that are expressly unallowable under applicable cost principles of the
FAR (ASUMF ¶ 5; R4, tab 1 at G-000099; FAR 52.242-4(c)(2)).
The dispute involves compensation to Ologyâs chief executive officer (CEO).
More specifically, it involves his salary, bonuses and stock option awards valued
at $2,730,686. Most of this amount stems from stock option awards valued
at $2,253,986 (GSMF ¶¶ 32-41; R4, tab 2 at G-0000160).
The contract referenced above included FAR 52.216-7, ALLOWABLE COST
AND PAYMENT (JUN 2011) (R4, tab 1 at G-000102-03). This clause required
Ology to submit its final indirect cost rate proposal within six months after the end of
its fiscal year, which for Ology was the calendar year. FAR 52.216-7(d)(2). Ology
complied with the clause by submitting its FY 2013 proposal on June 30, 2014. After
addressing issues identified by the Defense Contract Audit Agency (DCAA), it
submitted a revised proposal on December 18, 2014 (ASUMF ¶¶ 6, 22-23; GSMF
¶¶ 6, 22-23).
After a DCAA audit and a lengthy negotiation period between the parties
(ASUMF ¶¶ 25-30; GSMF ¶¶ 25-30), the CO issued a final decision on May 13, 2020.
Based on an FY 2013 cap for executive compensation of $980,796, the CO determined
that Ology had exceeded the cap and included expressly unallowable costs of
$1,749,8901 for its CEO in its indirect cost rate proposal. The CO found that $979,938
of this amount was allocated to covered contracts and assessed Ology a penalty in this
amount. In addition, she demanded interest that brought the total government claim to
$1,109,160 (ASUMF ¶¶ 1, 26, 31; GSMF ¶¶ 1, 26, 31).
DECISION
I. Summary Judgment Standards
Summary judgment is appropriate when there is no genuine issue of material
fact and the moving party is entitled to judgment as a matter of law. Anderson v.
Liberty Lobby, Inc., 477 U.S. 242, 247-48 (1986). When considering a motion for
summary judgment, the Board must determine whether there is a genuine issue for
1 $2,730,686 - $980,796 = $1,749,890
2
trial. Id. at 249.